BMN 111 administration via Injector Pen: Clinical Trials

1 trial of BMN 111 administration via Injector Pen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow BMN 111 administration via Injector Pen: new trials by email Literature Review of BMN 111 administration via Injector Pen trials Research Report on BMN 111 administration via Injector Pen

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Study to Compare Two Injection Devices for BMN 111 in Healthy Participants
BMN 111 administration via Injector Pen, BMN 111 administration via vial and syringe - Achondroplasia
Phase 1TerminatedBioMarin Pharmaceutical362023-03-152023-10-12

Conditions studied

Achondroplasia (1)

Sponsors

BioMarin Pharmaceutical (1)

Countries

United States (1)